ClearPoint Neuro (CLPT) Non-Current Assets (2011 - 2026)
ClearPoint Neuro (CLPT) posted Non-Current Assets of $38.5 million for Q1 2026, up 12.86% sequentially from $34.1 million in Q4 2025, and up 558.11% YoY from $5.9 million in Q1 2025.
ClearPoint Neuro (CLPT) Non-Current Assets (2011 - 2026) Analysis & Trends
ClearPoint Neuro has reported Non-Current Assets for 16 years, with the latest figure at $38.5 million in Q1 2026.
- Quarterly Non-Current Assets rose 558.11% year-over-year to $38.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90.6 million (up 284.47% YoY) and the FY2025 annual result came in at $34.1 million, up 486.11% from the prior year.
- Non-Current Assets rose to $38.5 million in Q1 2026 per CLPT's latest filing, from $34.1 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $38.5 million in Q1 2026 and troughed at $3.6 million in Q2 2022.
- A 5-year average of $9.4 million and a median of $6.0 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2026: Non-Current Assets decreased 13.16% in 2024, then soared 558.11% in 2026.
- Over 5 years, Non-Current Assets stood at $4.3 million in 2022, then surged by 50.56% to $6.5 million in 2023, then slipped by 10.22% to $5.8 million in 2024, then soared by 486.11% to $34.1 million in 2025, then increased by 12.86% to $38.5 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $38.5 million, $34.1 million, and $9.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 8.29 Bn |
| 10 | ClearPoint Neuro | 469.85 Mn | 440.45 Mn | 6.71 Mn | 37.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.81 Mn |
| Mar 31, 2026 | 38.54 Mn |
| Dec 31, 2025 | 34.15 Mn |
| Sep 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 8.88 Mn |
| Mar 31, 2025 | 5.86 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 5.86 Mn |
| Jun 30, 2024 | 6.02 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 6.49 Mn |
| Sep 30, 2023 | 6.53 Mn |
| Jun 30, 2023 | 6.93 Mn |
| Mar 31, 2023 | 4.26 Mn |
| Dec 31, 2022 | 4.31 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 3.76 Mn |
| Dec 31, 2021 | 3.69 Mn |
| Sep 30, 2021 | 3.71 Mn |